Viewing StudyNCT00426712



Ignite Creation Date: 2024-05-05 @ 5:18 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00426712
Status: COMPLETED
Last Update Posted: 2019-03-20
First Post: 2007-01-23

Brief Title: Safety of HEPLISAV Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients
Sponsor:
Organization: Dynavax Technologies Corporation